AstraZeneca Halts Vaccine Trial Due to Severe Adverse Effect

A test subject in the UK suffered a suspected serious adverse reaction. On Tuesday, AstraZeneca and eight other companies pledged to completely vet any vaccine before requesting permission for general use.

RIO DE JANEIRO, BRAZIL - AstraZeneca's vaccine is in the crucial trial phase with tens of thousands of participants and is considered a great hope. But now the pharmaceutical company has been forced to suspend its trials. One of the test subjects suffered a suspected serious adverse reaction.

The pharmaceutical company has halted the clinical trial of its coronavirus vaccine as a precautionary measure, after one of the subjects experienced adverse effects. This is a . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?